Thalidomide (drug)

DRUG2 trials

Sponsors

Charite University, Berlin, Germany, Shanghai Zhongshan Hospital

Conditions

Amyotrophic Lateral Sclerosis (ALS)Hepatocellular Carcinoma

Phase 2

Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)

TerminatedNCT00231140

Charite University, Berlin, GermanyAmyotrophic Lateral Sclerosis (ALS)

Start: 2005-12-31End: 2006-08-31Target: 40Updated: 2007-01-19

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

Not yet recruitingNCT07309419

Shanghai Zhongshan HospitalHepatocellular Carcinoma

Start: 2025-12-22End: 2030-06-30Target: 222Updated: 2025-12-30

Related Papers

Thalidomide causes sinus bradycardia in ALS.

2008-04-2125 citations